Management of Patients With Type 2 Diabetes and Hypertension Using Mobile Health Care System
NCT ID: NCT00489879
Last Updated: 2008-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2007-07-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Few studies have examined the effects of cellular phone based intervention that provide an interactive component daily. Our goal is to test the hypothesis that diabetes and hypertension management using cellular phone based health care system would result in significant improvement of blood glucose and blood pressure level.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobile Health Care System (DrUB)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 7% \< HbA1c \< 10%
* systolic blood pressure \> 130 or diastolic blood pressure \> 80
* BMI \> 23
* 20 \< age \< 75
Exclusion Criteria
* liver, renal or heart disease
* recent change (within 1 month) in the type or dosage of anti-diabetic agent, anti-hypertensive medication
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Korea University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kyung M Choi, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Internal Medicine, Korea University College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine, Korea University College of Medicine
Seoul, VD, South Korea
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kwon HS, Cho JH, Kim HS, Song BR, Ko SH, Lee JM, Kim SR, Chang SA, Kim HS, Cha BY, Lee KW, Son HY, Lee JH, Lee WC, Yoon KH. Establishment of blood glucose monitoring system using the internet. Diabetes Care. 2004 Feb;27(2):478-83. doi: 10.2337/diacare.27.2.478.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Seoul R&BD Program
Identifier Type: -
Identifier Source: org_study_id